Ad A M Masclee Selected Research

peppermint oil

11/2021	A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.
1/2021	A putative anti-inflammatory role for TRPM8 in irritable bowel syndrome-An exploratory study.
1/2020	Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
11/2018	A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ad A M Masclee Research Topics

Disease

12	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2022 - 11/2005
6	Abdominal Pain (Pain, Abdominal) 11/2021 - 11/2018
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2012
5	Inflammation (Inflammations) 05/2021 - 11/2005
5	Gastroesophageal Reflux (GERD) 01/2017 - 01/2003
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 12/2009
3	Pain (Aches) 01/2022 - 11/2013
3	Obesity 04/2021 - 01/2011
3	Fibrosis (Cirrhosis) 01/2021 - 11/2013
3	Crohn Disease (Crohn's Disease) 11/2020 - 08/2015
3	Adenoma (Adenomas) 01/2015 - 10/2011
3	Chronic Pancreatitis 11/2013 - 02/2004
2	Hypokalemia 07/2022 - 08/2021
2	Liver Diseases (Liver Disease) 01/2021 - 11/2013
2	Panic Disorder (Panic Attack) 01/2021 - 01/2019
2	Non-alcoholic Fatty Liver Disease 01/2021 - 12/2020
2	Type 2 Diabetes Mellitus (MODY) 10/2019 - 01/2016
2	Constipation 10/2019 - 04/2014
2	Overweight 01/2019 - 11/2016
2	Carcinogenesis 01/2017 - 10/2011
2	Colitis 01/2017 - 08/2014
2	Neoplasms (Cancer) 01/2016 - 03/2012
2	Polyps 01/2015 - 08/2013
2	Gallstones (Gallstone) 09/2007 - 04/2006
1	Hyponatremia 07/2022
1	Hyperphosphatemia 07/2022
1	Hypocalcemia 07/2022
1	Anxiety Disorders (Anxiety Disorder) 12/2021
1	Depressive Disorder (Melancholia) 12/2021
1	Hemochromatosis (Bronze Diabetes) 05/2021
1	Gastroparesis 02/2021
1	Visceral Pain 01/2021
1	Medically Unexplained Symptoms 01/2021
1	Lymphoma (Lymphomas) 10/2019
1	Diabetes Mellitus 10/2019
1	Cysts 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2017
1	Fistula 05/2017
1	Rheumatoid Arthritis 01/2017

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
4	peppermint oilIBA 11/2021 - 11/2018
3	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2011
3	Immunologic Factors (Immunomodulators)IBA 01/2018 - 12/2009
3	Biological ProductsIBA 01/2018 - 01/2015
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 07/2022 - 08/2021
2	DiureticsIBA 08/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 04/2021 - 01/2021
2	Hormones (Hormone)IBA 04/2021 - 02/2006
2	Escitalopram FDA Link 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 11/2020 - 12/2009
2	Volatile Fatty AcidsIBA 01/2019 - 01/2017
2	C-Reactive ProteinIBA 01/2017 - 08/2014
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2017 - 08/2014
2	Volatile Organic CompoundsIBA 01/2016 - 08/2015
2	salicylhydroxamic acid (SHAM)IBA 07/2014 - 01/2010
2	AcidsIBA 07/2014 - 09/2006
2	Nitroso CompoundsIBA 02/2012 - 10/2011
2	MotilinIBA 02/2006 - 05/2003
1	ElectrolytesIBA 07/2022
1	sodium phosphate (trisodium phosphate)FDA LinkGeneric 07/2022
1	Capsaicin (Zostrix)FDA Link 01/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 08/2021
1	ThiazidesIBA 08/2021
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 08/2021
1	IronIBA 05/2021
1	HepcidinsIBA 05/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2021
1	goblet cell silencer inhibitorIBA 02/2021
1	ethyl glucuronideIBA 01/2021
1	Menthol FDA Link 01/2021
1	NeuregulinsIBA 01/2021
1	AnkyrinsIBA 01/2021
1	AdipokinesIBA 01/2021
1	zonulinIBA 12/2020
1	SugarsIBA 12/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	Ustekinumab (CNTO 1275)FDA Link 10/2019
1	Radio-Opaque acrylic resinIBA 10/2019
1	Insulin-Like PeptidesIBA 10/2019
1	pyrazolanthroneIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	LipidsIBA 01/2019
1	AlginatesIBA 01/2019
1	Adalimumab (Humira)FDA Link 01/2019
1	EmulsionsIBA 01/2019
1	Virulence Factors (Pathogenicity Factors)IBA 12/2018
1	Capsules (Microcapsules)IBA 11/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	ProdrugsIBA 01/2017
1	Proton Pumps (Proton Pump)IBA 01/2017

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2003
4	Fundoplication 03/2015 - 01/2003
1	Pyloromyotomy 02/2021
1	Liver Transplantation 01/2021
1	Gastrostomy 11/2017
1	Conscious Sedation 11/2017
1	Biological Therapy 05/2017